Pre-Clinical Efficacy and Safety of Experimental Vaccines Based on Non-Replicating Vaccinia Vectors against Yellow Fever

• Birgit Schäfer,

  Affiliation Department of Virology, Baxter Bioscience, Biomedical Research Center, Orth/Donau, Austria

  ⨯
• Georg W. Holzer,

  Affiliation Department of Virology, Baxter Bioscience, Biomedical Research Center, Orth/Donau, Austria

  ⨯
• Alexandra Joachimsthaler,

  Affiliation Department of Virology, Baxter Bioscience, Biomedical Research Center, Orth/Donau, Austria

  ⨯
• Sogue Coulibaly,

  Affiliation Department of Animal Housing, Baxter Bioscience, Biomedical Research Center, Orth/Donau, Austria

  ⨯
• Michael Schwendinger,

  Affiliation Department of Immunology, Baxter Bioscience, Biomedical Research Center, Orth/Donau, Austria

  ⨯
• Brian A. Crowe,

  Affiliation Department of Immunology, Baxter Bioscience, Biomedical Research Center, Orth/Donau, Austria

  ⨯
• Thomas R. Kreil,

  Affiliation Global R&D Vaccines, Baxter Bioscience, Biomedical Research Center, Orth/Donau, Austria

  ⨯
• P. Noel Barrett,

  Affiliation Global R&D Vaccines, Baxter Bioscience, Biomedical Research Center, Orth/Donau, Austria

  ⨯
• Falko G. Falkner

  * E-mail: falknef@baxter.com

  Affiliation Department of Virology, Baxter Bioscience, Biomedical Research Center, Orth/Donau, Austria

  ⨯